Quelicin 200 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2D325F334T
- Awardee
-
Pfizer Inc. UEI MHBQULRMEEJ5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,397
Award facts
- Contract value 100% obligated
- $2,397.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10001, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense, through its Medical Supply Chain component, awarded a $2,397.00 firm fixed-price delivery order to Pfizer Inc. on August 20, 2025, for the supply of Quelicin 200 mg/10 ml vials. This single delivery order, which must be completed by August 21, 2025, represents a continuation of Pfizer's established role as a critical supplier of injectable medications and pharmaceutical products to federal healthcare agencies. The contract does not utilize a small business set-aside designation, reflecting Pfizer's status as a large, established pharmaceutical manufacturer capable of meeting extensive government medical supply requirements.
Pfizer's pharmaceutical supply to the Defense Logistics Agency's Medical Supply Chain occurs within the context of the company's substantial federal contracting portfolio, which includes two significant Indefinite Delivery Vehicle contracts valued at approximately $74.0 million and $46.9 million respectively. These overarching agreements enable Pfizer to fulfill delivery orders for critical medical interventions across multiple federal healthcare organizations, including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The delivery order for Quelicin, a succinct pharmaceutical product commonly used in medical settings, underscores Pfizer's ongoing commitment to supplying essential injectable medications to support federal government healthcare operations and military readiness.
Quick answers
Who was awarded contract SPE2D325F334T?
SPE2D325F334T was awarded to Pfizer Inc. by Medical Supply Chain (Troop Support) on August 20, 2025.
How much is contract SPE2D325F334T worth?
The government has obligated $2,397 on SPE2D325F334T.
Is contract SPE2D325F334T an order under another contract?
Yes. SPE2D325F334T is a delivery order under SPE2D020D0014, an indefinite delivery contract.
Was contract SPE2D325F334T competed?
The extent of competition for SPE2D325F334T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award